For issues not addressed in these instructions, the author is referred to the International Committee of Medical Journal Editors (ICMJE) “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (http://www.icmje.org). Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from: http://publicationethics.org/resources/flowcharts. If correction is needed, it will follow the ICMJE Recommendation for Corrections, Retractions, Republications and Version Control available from: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html.
1. Authorship and Copyright
① Authorship should be based on one of following contributions:
(a) substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work, (b) drafting the work or revising it critically for important intellectual content, (c) final approval of the version to be published, (d) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Any persons who do not meet the 4 criteria above should be placed as contributors in ACKNOWLEDGMENTS section.
② Upon the submission of manuscripts, all authors must sign and submit the “Copyright Transfer Agreement Form”, and it is not allowed to change the first or corresponding author, or to add or remove coauthor(s) once the manuscript is submitted to the journal website. The Copyright Transfer Agreement Form must be submitted via mail (to the main office of the Society), fax, or e-mail as scanned file.
③ If the each item of “Checklist for Submission” do not match the actual paper received, the manuscript can be resubmitted after returning the manuscript without reviewing.
④ The copyright for the manuscript published in this journal is owned by the Korean Society of Gastrointestinal Cancer Research. However, the legal responsibility for the content lies entirely with the authors. It is a violation of the regulations to present data on a paper that has been decided to be published but has not been published, and the use of published papers for commercial advertising purposes is prohibited. However, in case of an emergency in public health, prior consultation can be made with the society.
2. Conflict of Interest
The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing their interpretation of data. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. A potential conflict of interest should be disclosed in the manuscript even when the authors are confident that their judgments have not been influenced in preparing the manuscript. The disclosure form should be the same as the ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf
3. Ethical Considerations
- 1) When reporting experiments on human subjects, authors who submit manuscripts to Journal of Digestive Cancer Research should acquire the permission from the Institutional Review Board (IRB) on human experiment and indicate all possible physical and psychological damages on subjects and/or their guardians before the experiment is conducted, in accordance with the Helsinki Declaration of 1975 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/; revised in 2013).
- 2) Any information that could have revealed subjects’ identities, such as name and initials, should not appear in the text. If a photo is presented, proper measures should be taken not to reveal the subject’s identity, or a written consent must be presented for the photo and possible disclosure of subject’s identity.
- 3) When reporting experiments on animals, authors should describe the measures they have taken to ease pains and inconvenience on the subjects, and indicate whether the NIH Guide for the Care and Use of laboratory Animals or corresponding guideline was followed.
- 4) For unspecified yet necessary guidelines on the issues of legitimacy and ethics on the submitted manuscripts, authors may consult. International Standards for Editors and Authors by the Committee on Publication Ethics (COPE), which is available at http://publicationethics.org.
4. Registration of the Clinical Research and Data Sharing Policy
Any research that deals with clinical trial should be registered to the primary national clinical trial registration site such as http://cris.nih.go.kr/cris/index.jsp
, or other sites accredited by World Health Organization or ICMJE. This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors”.
The ICMJE's policy regarding trial registration is explained at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html.
If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.
5. Principles on overlapping publication
- ① The Society do not accept any manuscripts that are identical or significantly similar to studies already published or going to be published in other journals.
- ② It is not allowed for authors to publish their articles already appeared in JDCR without permission from the board. Multiple or duplicate publication is only limited to the cases specified in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Ann Intern Med 1997;126:36-47). This does not apply to the publication of abstracts or posters.
- ③ Authors are subject to penalties and/or unfavorable outcomes if unauthorized duplicate publication is discovered.